cerrar
Tagged with Research

Pfizer’s Bourla & MSD’s Frazier: No Cutting…
Top global pharma executives involved in the development of COVID-19 vaccines have stated their commitment to not rushing the release of any potential…

Ketil Widerberg – General Manager, Oslo Cancer Cluster,…
Ketil Widerberg of the Oslo Cancer Cluster highlights how Norway’s excellence in electronic health records can help the country stake out a position…

Anne Kjersti Fahlvik – Executive Director, Industries,…
Anne Kjersti Fahlvik of the Research Council of Norway highlights the health sector’s increasing importance to the Nordic nation, the country’s…

Opinion: The Paradigm Shift Needed for Effective Alzheimer’s…
Holmusk’s Nawal Roy outlines why a cure for Alzheimer’s Disease is the “Holy Grail” of medicine today, the reasons for so many biotech…

MSD to Build USD 1.3 Billion London Research Hub in Boon for…
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central London, with plans to open the…

Ryu Ogawa – CEO & Satoshi Tamaki – CSO, Molcure,…
Ryu Ogawa and Satoshi Tamaki of Japanese AI-powered drug discovery firm Molcure outline how their technology can supercharge the speed and efficiency…

In Profile: Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in Brussels since 1983. Initially planning…

Boehringer Ingelheim Creates New China External Innovation Hub
With its brand new hub in Shanghai dedicated to research, business development and venture funding, German pharma giant Boehringer Ingelheim is taking…

Jin LI – Chairman & CEO, HitGen, China
Dr Jin Li explains Chinese firm HitGen’s unique drug discovery technology platform, how its ability to screen billions of molecules has the…

3 Ways the UK’s Pharma Sector is Driving Innovation
Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical industry’s rapid response to…

New Billion Dollar Pharma Action Fund to Counter ‘Slow…
June 9th 2020 saw the launch of a new action fund on antimicrobial resistance (AMR), with 23 leading biopharmaceutical companies committing to almost…

Jeong-Sun Seo – Chairman, Macrogen & President, KoreaBIO
Dr Jeong-Sun Seo, chairman of Macrogen & president of the Korea Biotechnology Industry Organization (KoreaBIO), explains the basis for Korea’s…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here